tetano
Editor, Senior Moderator
Nat Rev Microbiol
. 2023 Jan 13.
doi: 10.1038/s41579-022-00846-2. Online ahead of print.
Long COVID: major findings, mechanisms and recommendations
Hannah E Davis[SUP] 1 [/SUP], Lisa McCorkell[SUP] 2 [/SUP], Julia Moore Vogel[SUP] 3 [/SUP], Eric J Topol[SUP] 4 [/SUP]
Affiliations
Abstract
Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated to have long COVID, with cases increasing daily. Biomedical research has made substantial progress in identifying various pathophysiological changes and risk factors and in characterizing the illness; further, similarities with other viral-onset illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome have laid the groundwork for research in the field. In this Review, we explore the current literature and highlight key findings, the overlap with other conditions, the variable onset of symptoms, long COVID in children and the impact of vaccinations. Although these key findings are critical to understanding long COVID, current diagnostic and treatment options are insufficient, and clinical trials must be prioritized that address leading hypotheses. Additionally, to strengthen long COVID research, future studies must account for biases and SARS-CoV-2 testing issues, build on viral-onset research, be inclusive of marginalized populations and meaningfully engage patients throughout the research process.
. 2023 Jan 13.
doi: 10.1038/s41579-022-00846-2. Online ahead of print.
Long COVID: major findings, mechanisms and recommendations
Hannah E Davis[SUP] 1 [/SUP], Lisa McCorkell[SUP] 2 [/SUP], Julia Moore Vogel[SUP] 3 [/SUP], Eric J Topol[SUP] 4 [/SUP]
Affiliations
- PMID: 36639608
- DOI: 10.1038/s41579-022-00846-2
Abstract
Long COVID is an often debilitating illness that occurs in at least 10% of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms have been identified with impacts on multiple organ systems. At least 65 million individuals worldwide are estimated to have long COVID, with cases increasing daily. Biomedical research has made substantial progress in identifying various pathophysiological changes and risk factors and in characterizing the illness; further, similarities with other viral-onset illnesses such as myalgic encephalomyelitis/chronic fatigue syndrome and postural orthostatic tachycardia syndrome have laid the groundwork for research in the field. In this Review, we explore the current literature and highlight key findings, the overlap with other conditions, the variable onset of symptoms, long COVID in children and the impact of vaccinations. Although these key findings are critical to understanding long COVID, current diagnostic and treatment options are insufficient, and clinical trials must be prioritized that address leading hypotheses. Additionally, to strengthen long COVID research, future studies must account for biases and SARS-CoV-2 testing issues, build on viral-onset research, be inclusive of marginalized populations and meaningfully engage patients throughout the research process.